Health
Three lessons from Covid-19 on accelerating biopharma innovation – STAT
Innovation in biopharma research and development being wrought by Covid-19 will improve R&D in cancer and other fields.
The health care research ecosystem has shifted into overdrive in response to Covid-19, sparking unprecedented speed and agility. The economic and public health burdens it has generated demand that we rethink our approach to developing new vaccines and therapies. Researchers are now examining what we can learn from these experiences and more broadly apply this innovation to research and development in the future.
As we look back at the past few months, I see three lessons that health care resear…
-
General21 hours agoAustralia loses ODI series to South Africa with defeat in second game in Mackay
-
General19 hours agoEveryday AI use brings a hidden climate cost
-
Noosa News23 hours agoBoat crash in Helensvale on the Gold Coast leaves man with life-threatening burns and another one injured
-
Noosa News22 hours agoBrisbane bands unite to help bassist’s cancer fight